Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23743375 | 0.88 | TSPO (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL23079918 | 0.82 | TSPO (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL25044110 | 0.82 | AKR1C4 (0.32) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL18542855 | 0.80 | RORC (0.38) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL25024928 | 0.79 | KDM4E (0.38) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL24208364 | 0.79 | KDM4E (0.36) | KDM4EL3MBTL1PTPN1MAPT | |
| SCHEMBL21266004 | 0.78 | PTGER4 (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL23282793 | 0.77 | TSPO (0.37) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL22431607 | 0.76 | TSPO (0.36) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL20990877 | 0.75 | KDM4E (0.44) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844267-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-12 | — | — | US | disclosed |
| US-20220416166-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844267-B2 | Organic electroluminescent materials and devices | L1CAM, LEF1, EPCAM | AKR1C4 4622/4885AKR1C3 4629/4885AKR1C2 4452/4885 |
| US-20220416166-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, LEF1, EPCAM | AKR1C4 4622/4885AKR1C3 4629/4885AKR1C2 4452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.